FTI CONSULTING, INC is 2.2x more valuable than Astrana Health, Inc. by market capitalization ($4.79 B vs $2.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FCN | ASTH |
|---|---|---|
| Market cap | $4.79 B | $2.22 B |
| US-listed rank | #1425 | #2042 |
| Revenue (latest FY) | $3.79B | $3.18B |
| Net income (latest FY) | $270.87M | $24.00M |
| Net margin | 7.1% | 0.8% |
| P/E (trailing FY) | 17.7 | 92.6 |
| SEC filings | 1,986 | 1,003 |
FTI CONSULTING, INC is 2.2x more valuable than Astrana Health, Inc. by market capitalization ($4.79 B vs $2.22 B).
In their latest fiscal years, FTI CONSULTING, INC reported $3.79B in revenue while Astrana Health, Inc. reported $3.18B.
Full pages: FTI CONSULTING, INC and Astrana Health, Inc., or browse the full rankings.